View in EDS HTML Full Text PDF Full Text

Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide.

Saved in:
Bibliographic Details
Title: Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide.
Authors: Shiota, Masaki1 (AUTHOR) shiota@uro.med.kyushu-u.ac.jp, Machidori, Asako1 (AUTHOR), Abe, Tatsuro1 (AUTHOR), Monji, Keisuke1 (AUTHOR), Kashiwagi, Eiji1 (AUTHOR), Takeuchi, Ario1 (AUTHOR), Takahashi, Ryosuke1 (AUTHOR), Inokuchi, Junichi1 (AUTHOR), Yokomizo, Akira2 (AUTHOR), Naito, Seiji2 (AUTHOR), Eto, Masatoshi1 (AUTHOR)
Source: International Journal of Urology. Dec2020, Vol. 27 Issue 12, p1109-1115. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09198172
DOI:10.1111/iju.14366